Composition : Voglibose 0.3mg
Form : Mouth Dissolving Tablets
/
Pack : 10 X 10s
/
Type : ALU ALU
Description : Voglibose should be co-administered in conjunction with diet treatment or diet plus oral hypoglycaemic drugs and dose titration must be recommended only if a response is not seen with 0.2 mg tid. The higher dose (0.3 mg three times daily) is effective in decreasing the reaction of VAT( visceral adipose tissue) to SATC (Subcutaneous Adipose Tissue) and glycaemic control was related to changes in VAT but not SATC.For IDDM patients, dose of 0.2 to 0.3 mg tid before meals is administered along with insulin administration -
J Clin Diagn Res. 2013 Dec; 7(12): 3023–3027
View more products with following salts
Voglibose 0.3mg